These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8111341)

  • 1. [Osteocalcin, marker of bone metabolism].
    Peretz A
    Bull Mem Acad R Med Belg; 1993; 148(1-2):90-6; discussion 97-9. PubMed ID: 8111341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in phospho-calcium metabolic factors in function of the rate of bone turnover. Epidemiologic study of osteoporosis (part 2)].
    Maini M; Brignoli E; Felicetti G; Bozzi M
    Minerva Med; 1996 Dec; 87(12):565-76. PubMed ID: 9064593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H; Schatz C; Pralle H; Ullmann J; Schatz H
    Dtsch Med Wochenschr; 1985 Sep; 110(38):1442-6. PubMed ID: 3875469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers of bone metabolism: application to understanding bone remodeling in children and adolescents.
    Levine MA
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():661-72. PubMed ID: 12795369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone metabolism markers in patients with Basedow-Graves disease].
    Vámos A; Balázs C
    Orv Hetil; 1997 Sep; 138(38):2403-5. PubMed ID: 9380378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological marker for bone turnover: Serum osteocalcin].
    Chaki O
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():245-9. PubMed ID: 18161113
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteocalcin. Biochemical considerations and clinical applications.
    Lian JB; Gundberg CM
    Clin Orthop Relat Res; 1988 Jan; (226):267-91. PubMed ID: 3275514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line.
    García-Pérez MA; Pineda B; Hermenegildo C; Tarín JJ; Cano A
    Fertil Steril; 2009 Apr; 91(4 Suppl):1347-50. PubMed ID: 18555220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of bone turnover--clinical application and limitations].
    Kusec V
    Lijec Vjesn; 2005; 127(5-6):139-45. PubMed ID: 16281476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers.
    Hauge EM; Qvesel D; Eriksen EF; Mosekilde L; Melsen F
    J Bone Miner Res; 2001 Sep; 16(9):1575-82. PubMed ID: 11547826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Osteocalcin (OC)].
    Wada S; Kamiya S
    Clin Calcium; 2006 Jun; 16(6):1017-21. PubMed ID: 16751699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin].
    Kong Y; Meng X; Zhou X; Liu H; Liu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteocalcin and hyperthyroidism].
    Pandolfi C; Montanari G; Mercantini F; Sbalzarini G
    Minerva Endocrinol; 1992; 17(2):75-8. PubMed ID: 1296147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
    Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
    Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
    Garnero P; Delmas PD
    Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone markers in osteoporosis and malignancy.
    Lipton A; Costa L; Demers LM
    Can J Oncol; 1995 Dec; 5 Suppl 1():11-5. PubMed ID: 8853519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.